港股異動丨易居企業(2048.HK)漲超8%創階段新高 近期獲南下資金持續加倉
格隆匯5月21日丨易居企業(2048.HK)拉昇漲8.1%,報9.31港元創8個月新高價,暫成交5335萬港元,總市值163億港元。據格隆匯APP顯示,近期南下資金大幅湧入易居,港股通持股比例從3月份的0.23%升至0.41%,持股比例接近翻倍。此外,4月底公司與阿里巴巴戰略合作再度升級。易居先以增發新股方式收購阿里巴巴所持有的天貓好房公司85%股份。與此同時,阿里巴巴和董事長周忻進行大舉增持,以及國內頂流私募基金雲峯基金斥巨資入股。市場人士指出,股東增持,知名基金入股,南下資金持續湧入的利好,足以反映出易居未來發展前景受到高度認可與支持。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.